Duke scientist's cancer research is questioned

Jul 23, 2010 By MARILYNN MARCHIONE , AP Medical Writer

(AP) -- Concerns are being raised about the validity of research done by a Duke University cancer scientist who recently was placed on leave while the school investigates whether he falsely claimed to be a Rhodes scholar.

The editor of a British journal, Lancet Oncology, issued an "expression of concern" Friday about a 2007 study by Duke's Dr. Anil Potti. It described that may help predict who most needs .

The journal says that some of Potti's co-authors contacted them this week with concerns about the report, which the medical journal is now investigating. Neither the scientist nor Duke officials could immediately be reached for comment.

Explore further: Surgery associated with better survival for patients with advanced laryngeal cancer

not rated yet
add to favorites email to friend print save as pdf

Related Stories

Spat between medical journals in England

Mar 16, 2007

A British medical publication has called on researchers to boycott another British medical journal, the Lancet, over its parent company's "warmongering."

Genomic signature of colon cancer may individualize treatment

Nov 24, 2008

Researchers in the Duke Institute for Genome Sciences & Policy have developed a model for predicting risk of recurrence in early stage colon cancer patients, and have used the model to also predict sensitivity to chemotherapy ...

When Genes Cooperate, Lung Cancer Grows and Spreads

Mar 09, 2009

(PhysOrg.com) -- The combined expression of three specific genes in lung cancer tumors may predict both cancer growth and a poorer prognosis, according to a study led by researchers in the Duke Institute for Genome Sciences ...

Recommended for you

User comments : 0